about
Evaluation and Management of Pulmonary Hypertension in Kidney Transplant Candidates and Recipients: Concepts and Controversies.Understanding medical care of transplant recipients through integrated registry and pharmacy claims data.Quantifying prognostic impact of prescription opioid use before kidney transplantation through linked registry and pharmaceutical claims data.Variation in Comedication Use According to Kidney Transplant Immunosuppressive Regimens: Application of Integrated Registry and Pharmacy Claims DataOPTN/SRTR 2015 Annual Data Report: Economics.The impact of kidney transplantation on heart failure risk varies with candidate body mass index.Impact of chronic obstructive pulmonary disease on elective and emergency abdominal aortic aneurysm repair.Depression diagnoses after living kidney donation: linking U.S. Registry data and administrative claims.Cancer diagnoses after living kidney donation: linking U.S. Registry data and administrative claimsInfluence of functional bowel disease on outcome of surgical antireflux procedures.Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients.OPTN/SRTR 2013 Annual Data Report: economics.MELD Exceptions and Rates of Waiting List Outcomes.Prognostic impact of mechanical ventilation after liver transplantation: a national database study.Associations of pre-transplant prescription narcotic use with clinical complications after kidney transplantationThoracic outlet decompression for subclavian vein thrombosis: experience in 71 patients.Novel methods for tracking long-term maintenance immunosuppression regimens.Clinical and economic consequences of first-year urinary tract infections, sepsis, and pneumonia in contemporary kidney transplantation practice.Cardiac evaluation before kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patients.Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured RecipientsPretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney TransplantationIncremental value of the pancreas allograft to the survival of simultaneous pancreas-kidney transplant recipients.Neuroma of the bile duct: a late complication after cholecystectomy.Transporting live donor kidneys for kidney paired donation: initial national results.The implications of acute rejection for allograft survival in contemporary U.S. kidney transplantation.The cost implications of first anniversary renal function after living, standard criteria deceased and expanded criteria deceased donor kidney transplantation.Economic and financial outcomes in transplantation: whose dime is it anyway?Transplant certification and quality assessment: time to take the front line?National assessment of early biliary complications after liver transplantation: economic implications.Antidepressant medication use before and after kidney transplant: implications for outcomes - A retrospective study.Associations of recipient illness history with hypertension and diabetes after living kidney donation.The Evolution of Organ Allocation for Liver Transplantation: Tackling Geographic Disparity Through Broader Sharing.Patient Safety Reporting: Lessons From the Blind Men and the Elephant.A commercial transplant network's perspective of value in solid organ transplantation: Strategizing for value in transplant care.The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis.Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation.Cultural competency of a mobile, customized patient education tool for improving potential kidney transplant recipients' knowledge and decision-making.Perioperative Complications After Living Kidney Donation: A National Study.Novel immunosuppression in pancreas transplantation and outcomes.Survival Implications of Opioid Use Before and After Liver Transplantation.
P50
Q30251773-7D821B5B-0083-4304-B108-4C299524C49CQ30692473-7EF0D3AD-FA71-4A30-A927-26DED83F4A52Q30881464-185E93F7-C186-4DF1-897B-36770969A677Q31049236-4750EB7E-478B-4AFC-BB14-D16C850C498BQ31152678-8B5CFA8B-699F-4769-A6CF-E91105BA0BF1Q33581566-A6B18492-83DA-4328-A724-9BCEF190E952Q34118253-AECD268B-9FA4-4DF3-88D6-2FA9FDE65C29Q34301597-D24614A5-F088-4EFB-BDB4-B4E0BEDD2ED6Q34349009-9FF1DBD7-4200-43DA-9D95-56D4084B664BQ34749548-790B9D98-8568-44DD-A5BB-C1828102775BQ35543289-B2C7BD07-7C48-42B5-8A99-8FD26E07CEF7Q35550010-33F34341-B9A2-42B5-B804-0CF06C26FD82Q35590424-70F7BF8B-92CA-4D9C-87F6-29201656A69BQ35688255-CF54CA52-E970-4E63-B34B-040DD4EF223BQ35908381-93C80A8C-5684-4138-AC6A-4F1E656F1512Q36012039-F6E52AAF-36C8-4167-A814-D29E5E78E0F2Q36666963-DC1125BE-AB36-4421-A514-DDE4785988B3Q36722992-4B6DE553-26E0-4876-B7E4-4E0BC506B6E4Q36736689-1BB65DAE-CA69-430F-A12A-84867729CA51Q36835081-6BB245A2-7864-4E0F-B4F4-D045B44EBA72Q36839878-4476FED7-9335-4405-99CF-1A895415CF3CQ37139473-46635897-E4DB-43D6-B304-202351449FB5Q37382067-F41F1CF8-DFDA-4EF7-92FE-66C4D6F952F0Q37832777-99DFB927-4540-4389-97B1-D79240248F8EQ38029899-2B5065BE-F0E7-45EB-AAEC-A5E0CFFEDE8EQ38035904-46950982-C575-47BA-B6A9-EFBCE461C28FQ38085507-1261A126-C556-43B1-BB15-191910160796Q38133469-D6B5F26B-2A89-4B13-BBF5-CD2A9F9ECEEEQ38239552-9CEF3CB2-37B7-4676-BEEC-E910444839DDQ38372758-828C6F77-67E2-4074-8BA9-74CA30CA4AE4Q38492196-25A64775-83B3-4685-A9E8-6A8E80D73D83Q38545360-4D64571B-1872-4F9E-968C-29D01ABC0DE1Q38694988-2661A61B-3E1A-45C1-97A3-EBD09531AAF3Q38723695-E30197A6-31EF-4C01-B2D6-1CE9864016EFQ38726037-19FCBA80-9378-48D3-93E2-5B571A19A979Q38824894-8F094618-FD17-4586-BE80-4E0978FD718CQ38927240-5BA7D3FF-24D4-4F7F-9FE3-D62C27A3959BQ38928418-1E8ABF18-C5CD-488F-8346-DED26141A547Q38993698-21A0463E-DEB3-46CA-9FBD-E142E7B3E9A6Q39062029-49E6DBE0-8EAD-4500-8076-8750717E1298
P50
description
researcher ORCID ID = 0000-0001-5684-0613
@en
wetenschapper
@nl
name
David Axelrod
@ast
David Axelrod
@en
David Axelrod
@es
David Axelrod
@nl
type
label
David Axelrod
@ast
David Axelrod
@en
David Axelrod
@es
David Axelrod
@nl
prefLabel
David Axelrod
@ast
David Axelrod
@en
David Axelrod
@es
David Axelrod
@nl
P1153
7102166382
P21
P31
P496
0000-0001-5684-0613